25.2.2006 Official Journal of the European Union L 55/51 COMMISSION DECISION of 24 February 2006 on introducing preventive vaccination against highly pathogenic avian influenza H5N1 and related provisions for movements in France (notified under document number C(2006) 632) (Only the French text is authentic) (2006/148EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Directive 2005/94/EC of 20 December 2005 on Community measures for the control of avian influenza and repealing Directive 92[40[EEC ('), and in particular, Article 57(2) thereof; Whereas: Avian influenza is an infectious viral disease in poultry and birds, causing mortality and disturbances which can quickly take epizootic proportions liable to present a serious threat to animal health and under certain circum- stances to human health. There is a risk that the disease agent might be spread to other holdings thus reducing sharply the profitability of poultry farming, to wild birds and from one Member State to other Member States and third countries through the international trade in live birds or their products. Highly pathogenic avian influenza A virus of subtype H5N1 has been isolated from wild birds in certain parts of the Community and in third countries adjacent to the Community or populated by migratory birds during winter. The likelihood of virus introduction with wild birds is increasing during the forthcoming migratory season. Early detection systems and biosecurity measures to reduce the risk of transmission of avian influenza to poultry flocks are in place in France. In its opinion on ‘Animal health and welfare aspects of avian influenza’ of 20 September 2005 the Animal Health and Welfare Panel of the European Food Safety Authority (EFSA) recommends that preventive vacci- nation can be considered if a high risk of virus intro- duction is identified in densely populated poultry areas. () OJ L 10, 14.1.2006, p. 16. However, such a practice should not jeopardise the strict biosecurity and other measures that should be in force in such areas aimed at eradicating any introduction of virus. On 21 February 2006, France has submitted to the Commission for approval a plan for preventive vacci- nation in the light of the particular risk of introduction of avian influenza in certain areas of its territory. The Commission has immediately examined this plan in collaboration with France and deems that after certain adaptations it is in conformity with the relevant Community provisions. It appears therefore appropriate to approve this plan. According to this plan France intends to vaccinate ducks and geese against highly pathogenic avain influenza H5N1. This should be considered as a ‘pilot project’ since there is limited experience with preventive vacci- nation in these species. Only vaccines authorised in accordance with Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (%) or Regulation No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (%) should be used. Where preventive vaccination is carried out in France monitoring on vaccinated and unvaccinated poultry flocks and movement restrictions for vaccinated birds have to be implemented. The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health, (®» OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive 2004/28[EC (O] L 136, 30.4.2004, p. 58). () OJ L 136, 30.4.2004, p. 1.